A Study to Collect Blood Biomarker Samples From Participants With Chronic Hepatitis B (CHB) Who Received Treatment With Pegasys (Peginterferon Alfa-2a) ± Nucleoside/Nucleotide Analogue
Clinical trial NCT01855997 · COMPLETED
Trial details
- NCT number
- NCT01855997
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2013-08-20
- Primary completion
- 2014-11-28
- Enrollment
- 1669
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.